C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma

著者: Mahner, S, Baasch, C, Schwarz, J, Hein, S, Wölber, L, Jänicke, F, Milde-Langosch, K
出版事項 2008

Saturation of tumour cell surface receptors for urokinase-type plasminogen activator by amino-terminal fragment and subsequent effect on reconstituted basement membranes invasion.

著者: Kobayashi, H., Ohi, H., Shinohara, H., Sugimura, M., Fujii, T., Terao, T., Schmitt, M., Goretzki, L., Chucholowski, N., Jänicke, F.
出版事項 1993

Risk-group discrimination in node-negative breast cancer using invasion and proliferation markers: 6-year median follow-up

著者: Harbeck, N, Dettmar, P, Thomssen, C, Berger, U, Ulm, K, Kates, R, Höfler, H, Jänicke, F, Graeff, H, Schmitt, M
出版事項 1999

Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer

著者: Dose-Schwarz, J, Tiling, R, Avril-Sassen, S, Mahner, S, Lebeau, A, Weber, C, Schwaiger, M, Jänicke, F, Untch, M, Avril, N
出版事項 2010

Expression Levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in Primary Breast Carcinoma and Distant Breast Cancer Metastases

著者: Ihnen, M., Köhler, N., Kersten, J. F., Milde-Langosch, K., Beck, K., Höller, S., Müller, V., Witzel, I., Jänicke, F., Kilic, E.
出版事項 2010

A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancer.

著者: Pedersen, N, Schmitt, M, Rønne, E, Nicoletti, M I, Høyer-Hansen, G, Conese, M, Giavazzi, R, Dano, K, Kuhn, W, Jänicke, F
出版事項 1993

Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc

著者: Kuhn, W, Schmalfeldt, B, Reuning, U, Pache, L, Berger, U, Ulm, K, Harbeck, N, Späthe, K, Dettmar, P, Höfler, H, Jänicke, F, Schmitt, M, Graeff, H
出版事項 1999

c-FOS suppresses ovarian cancer progression by changing adhesion

著者: Oliveira-Ferrer, L, Rößler, K, Haustein, V, Schröder, C, Wicklein, D, Maltseva, D, Khaustova, N, Samatov, T, Tonevitsky, A, Mahner, S, Jänicke, F, Schumacher, U, Milde-Langosch, K
出版事項 2014

Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer

著者: Ihnen, M, Wirtz, R M, Kalogeras, K T, Milde-Langosch, K, Schmidt, M, Witzel, I, Eleftheraki, A G, Papadimitriou, C, Jänicke, F, Briassoulis, E, Pectasides, D, Rody, A, Fountzilas, G, Müller, V
出版事項 2010

External quality assessment of trans-European multicentre antigen determinations (enzyme-linked immunosorbent assay) of urokinase-type plasminogen activator (uPA) and its type 1 in...

著者: Sweep, C. G., Geurts-Moespot, J., Grebenschikov, N., de Witte, J. H., Heuvel, J. J., Schmitt, M., Duffy, M. J., Jänicke, F., Kramer, M. D., Foekens, J. A., Brünner, N., Brugal, G., Pedersen, A. N., Benraad, T. J.
出版事項 1998

8p deletion is strongly linked to poor prognosis in breast cancer

著者: Lebok, P, Mittenzwei, A, Kluth, M, Özden, C, Taskin, B, Hussein, K, Möller, K, Hartmann, A, Lebeau, A, Witzel, I, Mahner, S, Wölber, L, Jänicke, F, Geist, S, Paluchowski, P, Wilke, C, Heilenkötter, U, Simon, R, Sauter, G, Terracciano, L, Krech, R, von der Assen, A, Müller, V, Burandt, E
出版年 Cancer Biol Ther (2015)

Partial PTEN deletion is linked to poor prognosis in breast cancer

著者: Lebok, P., Kopperschmidt, V., Kluth, M., Hube-Magg, C., Özden, C., B., Taskin, Hussein, K., Mittenzwei, A., Lebeau, A., Witzel, I., Wölber, L., Mahner, S., Jänicke, F., Geist, S., Paluchowski, P., Wilke, C., Heilenkötter, U., Simon, Ronald, Sauter, Guido, Terracciano, L., Krech, R., von d. Assen, A., Müller, V., Burandt, E.
出版年 BMC Cancer (2015)